News Author: Bruce Jancin Publish date: January 4, 2016
Key clinical point: Two-thirds of 16- to 19-year-olds have borderline or frank hypertension, hypercholesterolemia, and/or high blood glucose.
Majo...
News Author: Bruce Jancin Publish date: December 29, 2015
Current trends in surgical treatment of early-stage breast cancer.
News Author: Bruce Jancin Publish date: December 28, 2015
An adjuvant trastuzumab-based, nonanthracycline regimen for early HER2-positive breast cancer offers important cardiac safety benefits over the altern...
News Author: Bruce Jancin Publish date: December 23, 2015
Key clinical point: Oral nicotinamide is a safe, inexpensive vitamin, which may be of value in patients with disorders of skin barrier function, s...
News Author: Bruce Jancin Publish date: December 23, 2015
Transforming growth factor–beta inhibitor shows unprecedented effects in systemic sclerosis.
News Author: Bruce Jancin Publish date: December 23, 2015
Aspirin use protects against a known intermediate biomarker of breast cancer risk in a dose-dependent fashion.
News Author: Bruce Jancin Publish date: December 21, 2015
Key clinical point: T-DM1 as neoadjuvant monotherapy enables selected breast cancer patients to avoid neoadjuvant chemotherapy and/or endocrine th...
News Author: Bruce Jancin Publish date: December 18, 2015
Key clinical point: The significant benefit of delayed adjuvant neratinib following chemotherapy and trastuzumab remains unabated at 3 years&rsquo...
News Author: Bruce Jancin Publish date: December 17, 2015
Bisoprolol prevents the trastuzumab-related decline in left ventricular ejection fraction in breast cancer patients.
News Author: Bruce Jancin Publish date: December 17, 2015
Is neoadjuvant carboplatin for triple negative breast cancer ready for routine use?
News Author: Bruce Jancin Publish date: December 17, 2015
Nearly half of all children and adolescents with out-of-hospital cardiac arrest in 2013-2014 got bystander CPR.
News Author: Bruce Jancin Publish date: December 16, 2015
The investigational PD-L1 inhibitor avelumab showed clinical efficacy in specific subsets of metastatic breast cancer patients.
News Author: Bruce Jancin Publish date: December 14, 2015
Large analysis shows statin therapy doesn’t affect incidence of breast cancer.
News Author: Bruce Jancin Publish date: December 14, 2015
Particularly close monitoring for adverse breast cancer outcomes is warranted for women with an infection-related hospitalization during the first yea...
Video Author: Bruce Jancin Publish date: December 14, 2015
